Corporate Board Profile
Tech Score: 0/100
Filing Date | Source Excerpt |
---|---|
2011-04-29 | Dr. Douglas received a Ph.D. from the University of California, Berkeley in biochemistry and has biotechnology experience. |
2012-04-30 | Dr. Douglas was a postdoctoral fellow in Leroy Hoods laboratory at the California Institute of Technology. He received a Ph.D. from the University of California, Berkeley in biochemistry and a B.S. in chemistry from the University of Michigan. |
2013-04-30 | Former Senior Vice President Corporate Development and a Corporate Officer of Genzyme Corporation. From 1989 to 2011 he led Genzyme's Corporate Development team. Dr. Douglas was a postdoctoral fellow in Leroy Hood's laboratory at the California Institute of Technology. He received a Ph.D. from the University of California, Berkeley in biochemistry and a B.S. in chemistry from the University of Michigan. |
2014-04-30 | Former Senior Vice President Corporate Development, Genzyme Corporation. From 1989 to 2011, Dr. Douglas led Genzyme Corporation’s Corporate Development team, and was involved in numerous acquisitions, licenses, financings, joint ventures, and strategic alliances. From 1982 until its merger with Genzyme Corporation in 1989, Dr. Douglas served in science and corporate development capacities at Integrated Genetics. Dr. Douglas was a postdoctoral fellow in Leroy Hood’s laboratory at the California Institute of Technology. Dr. Douglas serves on the University of Michigan Technology Transfer National Advisory Board. Dr. Douglas received a Ph.D. from the University of California, Berkeley in biochemistry and a B.S. in chemistry from the University of Michigan. We believe that Dr. Douglas is well-suited to serve on our Board due to his significant business experience and scientific background. |
2015-04-30 | Dr. Douglas received a Ph.D. from the University of California, Berkeley in biochemistry and a B.S. in chemistry from the University of Michigan. We believe that Dr. Douglas is well-suited to serve on our Board due to his significant business experience and scientific background. |
2016-04-20 | Dr. Douglas received a B.S. in chemistry from the University of Michigan and a Ph.D. in biochemistry from the University of California, Berkeley. |
2017-04-28 | Dr. Douglas received a B.S. in chemistry from the University of Michigan and a Ph.D. in biochemistry from the University of California, Berkeley. |
2018-04-30 | Dr. Douglas received a B.S. in chemistry from the University of Michigan and a Ph.D. in biochemistry from the University of California, Berkeley. We believe that Dr. Douglas is well-suited to serve on our Board due to his significant business experience and scientific background. |
2019-04-01 | Richard H. Douglas, Ph.D. is listed as a director with no indication of software or technical background. |
2019-05-16 | Dr. Douglas received a B.S. in chemistry from the University of Michigan and a Ph.D. in biochemistry from the University of California, Berkeley. We believe that Dr. Douglas is well-suited to serve on our Board due to his significant business experience and scientific background. |
2020-05-13 | Dr. Douglas received a B.S. in chemistry from the University of Michigan and a Ph.D. in biochemistry from the University of California, Berkeley. We believe that Dr. Douglas is well-suited to serve on our Board due to his significant business experience and scientific background. |
2021-05-03 | Ph.D. in Biochemistry, University of California, Berkeley; Bachelor of Science in Chemistry, University of Michigan |
2022-05-02 | Dr. Douglas is well-suited to serve on our Board due to his significant business experience and scientific background. |
2023-04-28 | Ph.D. in Biochemistry, University of California, Berkeley; Bachelor of Science in Chemistry, University of Michigan |
2024-04-29 | Ph.D. in Biochemistry, University of California, Berkeley; Bachelor of Science in Chemistry, University of Michigan |
Data sourced from SEC filings. Last updated: 2025-10-11